| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/13/2010 | EP2143795A2 Anti-CD20 monoclonal antibody |
| 01/13/2010 | EP2143734A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof |
| 01/13/2010 | EP2143714A1 Tetrahydroisoquinoline compound |
| 01/13/2010 | EP2143445A1 Medicated patch |
| 01/13/2010 | EP2143444A1 Compositions for inhibition of anglogenesis |
| 01/13/2010 | EP2143424A1 Oral pharmaceutical preparation for colon-specific delivery |
| 01/13/2010 | EP2142664A1 Estimation and biological consequences of oxidative metabolism |
| 01/13/2010 | EP2142531A1 Benzimidazole cannabinoid agonists |
| 01/13/2010 | EP2142517A2 Quinazoline compounds |
| 01/13/2010 | EP2142516A1 Pyrimidine hydrazide compounds as pgds inhibitors |
| 01/13/2010 | EP2142512A2 Imidazolidine carboxamide derivatives as p2x7 modulators |
| 01/13/2010 | EP2142502A1 Pyrrole and isoindole carboxamide derivatives as p2x7 modulators |
| 01/13/2010 | EP2142182A1 Composition comprising terpene compounds and methods for inhibiting nerve transmission |
| 01/13/2010 | EP1778622B1 Para-alkyl-substituted n-(4-hydroxy-3-methoxy-benzyl) cinnamamides and the use thereof for producing drugs |
| 01/13/2010 | EP1487453B1 N- ¬(2s)-4-(3,4-difluorobenzyl)morpholin-2-yl methyl -2- 3-¬(methylsulphonyl)amino phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions |
| 01/13/2010 | EP1465886B1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/13/2010 | EP1406910B1 Preparation methods of derivatives of bisphosphonates |
| 01/13/2010 | EP1360500B1 Methods for selective targeting |
| 01/13/2010 | EP1305322B1 Derivatives of branched-chain lipophilic molecules and uses thereof |
| 01/13/2010 | EP1144388B1 Acyl derivatives which treat vla-4 related disorders |
| 01/13/2010 | CN201379811Y Muscle and bone plaster |
| 01/13/2010 | CN100579984C Orally administered peptides to ameliorate atherosclerosis |
| 01/13/2010 | CN100579968C Quinazolinone derivatives and their use as CB agonists |
| 01/13/2010 | CN100579568C Oral Chinese-medicinal composition for treating difficult menstruation |
| 01/13/2010 | CN100579555C Chinese medicine for treating acute appendicitis and preparing method thereof |
| 01/13/2010 | CN100579551C Medicine for treating wind-damp arthralgia and hyperosteogeny |
| 01/13/2010 | CN100579546C Chinese medicinal liquid for treating rheumatic arthritis and rheumatoid arthritis |
| 01/13/2010 | CN100579541C Medicinal liquor for treating rheumatism and rheumatoid diseases |
| 01/13/2010 | CN100579537C Centella soft capsule and its preparing method |
| 01/13/2010 | CN100579534C Application of S-adenyhomotype cysteine in medical preparation |
| 01/13/2010 | CN100579517C 'Longxuejie' soft capsule and preparation method thereof |
| 01/13/2010 | CN100579379C Ageratum tea |
| 01/12/2010 | US7645797 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 01/12/2010 | US7645784 Benzimidazole derivatives |
| 01/12/2010 | US7645779 Linked biaryl compounds |
| 01/12/2010 | US7645774 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis |
| 01/12/2010 | US7645770 Phenylalanine enamide derivatives |
| 01/12/2010 | US7645768 Production of polyketides and other natural products |
| 01/12/2010 | US7645760 1-(4-Benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 01/12/2010 | US7645757 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/12/2010 | US7645754 Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use |
| 01/12/2010 | US7645601 Isolated PGE synthase, provided from encoding nucleic acid. Methods of production and use. Assays for modulators, especially inhibitors, of PGE synthase activity. |
| 01/12/2010 | US7645464 Useful application of by-products from the production of shea butter fat and mowrah fat, producing low-cost and high-quality saponin/sapogenin containing extracts; use in skin care products, cosmetics, foods |
| 01/12/2010 | CA2483678C 6-11 bicyclic ketolide derivatives |
| 01/12/2010 | CA2481461C Derivatives of n-[phenyl(piperidin-2-yl) methyl] benzamide, the preparation method thereof and application of same in therapeutics |
| 01/12/2010 | CA2461946C Combinations for the treatment of immunoinflammatory disorders |
| 01/12/2010 | CA2442906C Reconstitutable parenteral composition containing a cox-2 inhibitor |
| 01/12/2010 | CA2407838C Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/12/2010 | CA2407463C N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 01/12/2010 | CA2387675C Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 01/12/2010 | CA2201781C Chronic rheumatoid arthritis therapy containing il-6 antagonist as effective component |
| 01/12/2010 | CA2192089C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/07/2010 | WO2010003022A1 Isoindolone derivatives as mek kinase inhibitors and methods of use |
| 01/07/2010 | WO2010002820A1 Aza-indoles and related compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 01/07/2010 | WO2010001990A1 Tetracyclic compound |
| 01/07/2010 | WO2010001869A1 Tetra-substituted benzene compound and use thereof |
| 01/07/2010 | WO2010001365A1 Nitrogen heterocycle derivatives as proteasome modulators |
| 01/07/2010 | WO2010001258A2 Inhibition of tumour growth and metastases |
| 01/07/2010 | WO2010001179A2 Calcium ion channel modulators & uses thereof |
| 01/07/2010 | WO2010001126A1 Thiophene derivatives as kinase inhibitors |
| 01/07/2010 | WO2010001096A2 Treatment |
| 01/07/2010 | WO2010000730A1 Immunosuppressive blood cells and methods of producing same |
| 01/07/2010 | WO2010000564A2 Rooibos and inflammation |
| 01/07/2010 | WO2010000429A1 Adenine receptor ligands |
| 01/07/2010 | WO2009143024A3 Compounds and methods for kinase modulation, and indications therefor |
| 01/07/2010 | WO2009138758A3 Bis-aryl compounds for use as medicaments |
| 01/07/2010 | WO2009131687A3 Inhibitors of protein kinases |
| 01/07/2010 | WO2009129494A3 Alpha and beta adrenergic receptor agonists for treatment of pain and/or inflammation |
| 01/07/2010 | WO2009129464A3 Method for treating acute pain with a formulated drug depot in combination with a liquid formulation |
| 01/07/2010 | WO2009129155A3 Dexamethasone formulations in a biodegradable material |
| 01/07/2010 | WO2008149168A8 Triazolo [1, 5-a] quinolines as adenosine a3 receptor ligands |
| 01/07/2010 | US20100004327 Novel Use of Ansamycin Antibiotics And Method of Screening Novel Angiogenesis Inhibitor |
| 01/07/2010 | US20100004319 Composition and Method for the Prevention, Treatment and/or Alleviation of an Inflammatory Disease |
| 01/07/2010 | US20100004305 Naphthylmethylimidizoles as therapeutic agents |
| 01/07/2010 | US20100004298 P-38 inhibitors |
| 01/07/2010 | US20100004293 Crystalline forms of aryl-substituted pyrazole-amide compounds |
| 01/07/2010 | US20100004264 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 01/07/2010 | US20100004261 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 01/07/2010 | US20100004254 Therapeutic agents useful for treating pain |
| 01/07/2010 | US20100004246 Novel triazinedione derivatives as gabab receptor modulators |
| 01/07/2010 | US20100004236 Phosphodiesterase 4 inhibitors |
| 01/07/2010 | US20100004227 Compositions and methods relating to novel compounds and targets thereof |
| 01/07/2010 | US20100004219 Modulators of glucocorticoid receptor, ap-1, and/or nf-kappabeta activity and use thereof |
| 01/07/2010 | US20100004217 Topical steroidal formulations |
| 01/07/2010 | US20100004200 Meloxicam and glucosamine formulation and uses thereof |
| 01/07/2010 | US20100004196 Heparan sulfate proteoglycan composition and use thereof |
| 01/07/2010 | US20100004174 Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases |
| 01/07/2010 | US20100004172 Compositions for mucosal and oral administration comprising hcg fragments |
| 01/07/2010 | US20100004159 Substituted imidazolone derivatives, preparations and uses |
| 01/07/2010 | US20100003323 Hydrophilic matrix containing poorly water-soluble compound and method for producing the same |
| 01/07/2010 | US20100003309 Method for the production of fentanyl-based anesthetics for their oral transmucosal administration in a candy-like dosage form |
| 01/07/2010 | US20100003249 Polypeptide constructs for topical administration |
| 01/07/2010 | US20100003248 Polypeptide constructs for rectal and/or vaginal administration |
| 01/07/2010 | US20100003233 Compositions and methods for treatment of microbial infections |
| 01/07/2010 | CA2729780A1 Methods and compositions for reducing inflammation and treating inflammatory disorders |
| 01/07/2010 | CA2729745A1 Oxindole compounds |
| 01/07/2010 | CA2729688A1 Calcium ion channel modulators & uses thereof |
| 01/07/2010 | CA2729681A1 Heterocyclic derivatives as modulators of ion channels |
| 01/07/2010 | CA2729552A1 Aza-indoles and related compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 01/07/2010 | CA2728769A1 Nitrogen heterocycle derivatives as proteasome modulators |